Home | Contact Us | Sitemap
In this Section In this Section
Other links Other links
Events Calendar
Latest News and Research Latest News and Research The IMNDA Shortlisted for an award! The IMNDA Shortlisted for an award! Thursday, 16th May 2013
We are delighted to announce that our nomination for Certus Charity of the Year partnership has been shortlisted for an ...


Response to advert re alleged MND Treatment Response to advert re alleged MND Treatment Wednesday, 8th May 2013
One of our supporters kindly brought this worrying advert to our attention, it has been in the Phoenix Magazine recently. ...


The IMNDA and TCD MND Research Drinking Tea for MND The IMNDA and TCD MND Research Drinking Tea for MND Tuesday, 26th March 2013
Every year since 1997, the MND community worldwide has marked 21st June as the global day of recognition of ALS/MND - a ...


Read more news and research


Newsletter Newsletter Subscribe to receive our latest news and offers
subscribe unsubscribe



Diagnosis and Treatment

Medical Report

What help is available?



Many of the symptoms and subsequent problems can be effectively alleviated by your consultant or G.P. In addition, other professionals such as the physiotherapist, occupational therapist, nurse, social worker, speech therapist and dietician, can be an invaluable source of help. A range of leaflets dealing with specific problem areas is available from the
association on request.

What is Rilutek?



Rilutek (riluzole) is the first and, to date, only drug licensed for the treatment of Motor Neurone Disease. It is not a cure, it does not prevent, halt or reverse the disease but it has been shown to have an effect in extending life in both the limb and bulbar onset forms of MND. In studies, patients taking Rilutek were shown to have an increased life expectancy.

Life Expectancy

This is variable from three to five years (or occasionally longer) after onset, depending on the activity of the disease and the particular muscle groups affected.

Home | About IMNDA | About MND | Just diagnosed | Contact Us Copyright IMNDA 2013. All rights reserved. Powered by BESTSOFT Consulting Ltd.